Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide
JCO Oncol Pract
.
2024 Feb 27:OP2300579.
doi: 10.1200/OP.23.00579.
Online ahead of print.
Authors
Charles L Bennett
1
2
,
Jason B Gibbons
2
,
Antonio Trujillo
3
,
Kenneth R Carson
4
,
Kevin Knopf
1
,
Chadi Nabhan
1
,
Steven T Rosen
4
5
,
David M Aboulafia
5
Affiliations
1
SmartState Center for Medication Safety and Efficacy at the University of South Carolina, Columbia, SC.
2
Department of Health Systems Management and Policy, Colorado School of Public Health, Denver, Colorado.
3
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
4
Department of Hematology/Hematopoietic Cell Transplantation, The City of Hope Comprehesive Cancer Center, Duarte, CA.
5
Floyd and Delores Jones Cancer Institute at Virginia Mason, Seattle, WA.
PMID:
38412398
DOI:
10.1200/OP.23.00579
No abstract available